Delayed administration of nafamostat mesylate inhibits thrombin-mediated blood–spinal cord barrier breakdown during acute spinal cord injury in rats

Abstract

Background Nafamostat mesylate (nafamostat, NM) is an FDA-approved serine protease inhibitor that exerts anti-neuroinflammation and neuroprotective effects following rat spinal cord injury (SCI). However, clinical translation of nafamostat has been limited by an unclear administration time window and mechanism of action. Methods Time to first dose of nafamostat administration was tested on rats after contusive SCI. The optimal time window of nafamostat was screened by evaluating hindlimb locomotion and electrophysiology. As nafamostat is a serine protease inhibitor known to target thrombin, we used argatroban (Arg), a thrombin-specific inhibitor, as a positive control in the time window experiments. Western blot and immunofluorescence of thrombin expression level and its enzymatic activity were assayed at different time points, as well its receptor, the protease activated receptor 1 (PAR1) and downstream protein matrix metalloproteinase-9 (MMP9). Blood–spinal cord barrier (BSCB) permeability leakage indicator Evans Blue and fibrinogen were analyzed along these time points. The infiltration of peripheral inflammatory cell was observed by immunofluorescence. Results The optimal administration time window of nafamostat was 2–12 h post-injury. Argatroban, the thrombin-specific inhibitor, had a similar pattern. Thrombin expression peaked at 12 h and returned to normal level at 7 days post-SCI. PAR1, the thrombin receptor, and MMP9 were significantly upregulated after SCI. The most significant increase of thrombin expression was detected in vascular endothelial cells (ECs). Nafamostat and argatroban significantly downregulated thrombin and MMP9 expression as well as thrombin activity in the spinal cord. Nafamostat inhibited thrombin enrichment in endothelial cells. Nafamostat administration at 2–12 h after SCI inhibited the leakage of Evans Blue in the epicenter and upregulated tight junction proteins (TJPs) expression. Nafamostat administration 8 h post-SCI effectively inhibited the infiltration of peripheral macrophages and neutrophils to the injury site. Conclusions Our study provides preclinical information of nafamostat about the administration time window of 2–12 h post-injury in contusive SCI. We revealed that nafamostat functions through inhibiting the thrombin-mediated BSCB breakdown and subsequent peripheral immune cells infiltration.

Efficacy and safety of Nafamostat mesylate in patients with end-stage renal failure

“…The inclusion criteria were as follows: (1) Availability of complete clinical data; (2) Meeting the relevant diagnostic criteria for end-stage renal failure diagnosis[ 7 ]; and (3) The patients were informed about the study, and informed consent was obtained from the patients and their families.…”

Exploration of the effect and potential mechanism of quercetin in repairing spinal cord injury based on network pharmacology and in vivo experimental verification

“…The protocol of the immunofluorescence refers to the previous study of the team [ 21 ]. The rats were perfused with 4 °C PBS, followed by 4% paraformaldehyde.…”

“…The protocol of the Western Blotting experiment refers to the previous study of our team [ 21 , 22 ]. Injured spinal cord epicenters 0.5 cm in size were harvested from 6 individual rats and lysed by homogenization in RIPA Lysis Buffer (P0013B, Beyotime) (100 μL/10 mg spinal cord) with PhosSTOP (04906837001; phosphatase inhibitor) and cOmplete (04693132001; protease inhibitor) from Roche (Mannheim, Germany).…”

Cerium Oxide Nanoparticles Alleviate Neuropathic Pain by Modulating Macrophage Polarization in a Rat SCI Model

“…An established spinal cord contusion injury-induced neuropathic pain model was adopted. 18 , 19 After anesthesia satisfaction, the T10 laminectomy was performed and the adjacent spinous process of T9 and T11 were clamped to stabilize the spinal column. The rats were then transferred to the New York University Impactor device (NYU) machine and the exposed spinal T10 segment was contused using a 10 g rob falling from a height of 25 cm.…”